Email Updates

Search form

You are here

Webinar & Meeting Reports

  • July 17, 2016 to July 22, 2016

    The International AIDS Conference, or AIDS 2016, is a biennial gathering for those working in the field of HIV, as well as policy makers, persons living with HIV and other individuals committed to ending the epidemic. Sixteen years after Durban 2000, the first (and only) International AIDS Conference held in Africa, the large international gathering returns to South Africa this July.

  • July 14, 2016

    Professor Gail Henderson, PhD describes what regulatory processes are in place to keep participants in HIV cure research safe. In this webinar, she described the relationship between informed consent and ethical research, identified challenges of discussions around risks and benefits and provided points of considerations for the informed consent process.

  • July 13, 2016

    The case of the “Mississippi child” has intrigued scientists since the case was first announced as "cured" in 2013. After the Mississippi child rebounded after two years of remission little has been mentioned about pediatric HIV cure research in the media. This webinar answered the essential questions about the state of the research and discussed the opportunities and challenges in pursuing curative strategies in pediatric populations.

  • July 13, 2016 to July 15, 2016

    Women Now! 2016 will provide an opportunity to assess the content and execution of the International AIDS Conference 2016. The Pan African Women’s Summit will provide an opportunity to assess the content and execution of the IAC for its meaningful inclusion of women’s and girls’ sexual & reproductive health and justice, especially women and girls of African descent, who bear the brunt of the HIV pandemic among women worldwide.

  • July 7, 2016

    Listen here for a recording of the Fellows Program informational call.

  • June 29, 2016

    The HIV cure research field presents new challenges to study conduct, design, risk and a host of other issues — scientific, biological, social, ethical and regulatory — that many stakeholders are grappling with. This module will begin to unpack some of the ethical issues associated with HIV cure research.

  • June 23, 2016

    Early ART does not cure HIV. However, researchers globally are looking to understand why some HIV-positive individuals can achieve a temporary remission while others rebound quickly after stopping treatment. This module gave an overview of the current research landscape and place early ART research in the larger framework of the HIV cure research agenda. The webinar was led by Dr. Jintanat Ananworanich, MD, PhD.

  • June 20, 2016

    This full day symposium will focus on progress being made in HIV cure research. It will highlight (1) research to improve stem cell transplants; (2) gene editing technology; (3) advances in immune modulators and latency reversing agents; (4) ethical concerns related to treatment interruption and patient risk; and (5) policy barriers.

  • June 16, 2016

    Based on the AVAC/UNAIDS Good Participatory Practice Guidelines (GPP), this module applies the principles found in the guidelines to early phase HIV cure research. The content is designed to help research teams, community members and other stakeholders understand and implement GPP in early phase research.

  • June 15, 2016
    For the first time, two large-scale studies have confirmed modest efficacy for a microbicide to prevent HIV. In this webinar, we discussed why the ring results were greeted with disappointment by some and joy by others, what plans are there to introduce the ring into prevention programs and what role can/should such biomedical tools play within the overall response to HIV.